Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CYTEK BIOSCIENCES INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 832 shares of CTKB (CYTEK BIOSCIENCES INC), worth $4,202 as of 2025-Q4. This is a new position.
Current Value
$4,202
Current Shares
832
Total Value Change
-$1.1M
Total Shares Change
-198,321
Other major holders of CTKB: RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., BlackRock Finance, Inc.
New |
| 832 |
- |
| $4,202 |
| 0.0% |
| $5.04 |
22 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $3.38 | 0 |
| 2025-Q2 | Increased | 284,350 | +48.4% | $966,790 | 0.0% | $3.55 | 34 |
| 2025-Q1 | Decreased | 191,624 | -2.8% | $768,412 | 0.0% | $4.00 | 0 |
| 2024-Q4 | Increased | 197,058 | +12.8% | $1.3M | 0.0% | $6.55 | 29 |
| 2024-Q3 | Decreased | 174,625 | -12.3% | $967,423 | 0.0% | $5.39 | 0 |
| 2024-Q2 | Increased | 199,153 | +60.4% | $1.1M | 0.0% | $5.58 | 36 |